1. Home
  2. CLST vs QNCX Comparison

CLST vs QNCX Comparison

Compare CLST & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLST
  • QNCX
  • Stock Information
  • Founded
  • CLST 1922
  • QNCX 2012
  • Country
  • CLST United States
  • QNCX United States
  • Employees
  • CLST N/A
  • QNCX N/A
  • Industry
  • CLST
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CLST
  • QNCX Health Care
  • Exchange
  • CLST Nasdaq
  • QNCX Nasdaq
  • Market Cap
  • CLST 51.0M
  • QNCX 44.0M
  • IPO Year
  • CLST N/A
  • QNCX 2019
  • Fundamental
  • Price
  • CLST $11.10
  • QNCX $0.99
  • Analyst Decision
  • CLST
  • QNCX Strong Buy
  • Analyst Count
  • CLST 0
  • QNCX 5
  • Target Price
  • CLST N/A
  • QNCX $8.00
  • AVG Volume (30 Days)
  • CLST 5.3K
  • QNCX 134.5K
  • Earning Date
  • CLST 05-01-2025
  • QNCX 05-12-2025
  • Dividend Yield
  • CLST N/A
  • QNCX N/A
  • EPS Growth
  • CLST N/A
  • QNCX N/A
  • EPS
  • CLST N/A
  • QNCX N/A
  • Revenue
  • CLST $5,174,000.00
  • QNCX N/A
  • Revenue This Year
  • CLST N/A
  • QNCX N/A
  • Revenue Next Year
  • CLST N/A
  • QNCX N/A
  • P/E Ratio
  • CLST N/A
  • QNCX N/A
  • Revenue Growth
  • CLST N/A
  • QNCX N/A
  • 52 Week Low
  • CLST $10.67
  • QNCX $0.51
  • 52 Week High
  • CLST $12.10
  • QNCX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • CLST 39.14
  • QNCX 25.41
  • Support Level
  • CLST $10.87
  • QNCX $0.93
  • Resistance Level
  • CLST $11.31
  • QNCX $1.04
  • Average True Range (ATR)
  • CLST 0.21
  • QNCX 0.10
  • MACD
  • CLST -0.03
  • QNCX -0.02
  • Stochastic Oscillator
  • CLST 40.57
  • QNCX 13.47

About CLST Catalyst Bancorp Inc.

Catalyst Bancorp Inc is a federally chartered community-oriented savings bank. The bank is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources which are used for the origination of loans. The Bank derives its income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: